Загрузка...
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry
The Recurrence Score® is increasingly used in node-positive ER+ HER2-negative breast cancer. This retrospective analysis of a prospectively designed registry evaluated treatments/outcomes in node-positive breast cancer patients who were Recurrence Score-tested through Clalit Health Services from 1/2...
Сохранить в:
Опубликовано в: : | NPJ Breast Cancer |
---|---|
Главные авторы: | , , , , , , , , , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Nature Publishing Group UK
2017
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5591314/ https://ncbi.nlm.nih.gov/pubmed/28900632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-017-0033-7 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|